NDC 0088-2500 – Apidra

Insulin Glulisine 100 [iU]/mL · Injection, Solution · Intravenous, Subcutaneous

Human Prescription Drug

Product NDC0088-2500

Product details

Brand name
Apidra
Generic name
Insulin glulisine
Labeler
sanofi-aventis U.S. LLC
Dosage form
Injection, Solution
Route
Intravenous, Subcutaneous
Marketing category
BLA · BLA021629
Marketed since
February 24, 2009
Listing expires
December 31, 2026
Pharmacologic class
Insulin Analog

Active ingredients

Uses, dosage, side effects and warnings for Apidra →

Package NDC codes (2)

Package NDCDescriptionSince
0088-2500-331 VIAL, GLASS in 1 CARTON (0088-2500-33) / 10 mL in 1 VIAL, GLASSFeb 24, 2009
0088-2500-341 VIAL, GLASS in 1 CARTON (0088-2500-34) / 10 mL in 1 VIAL, GLASSFeb 24, 2009